# Escalade Inc: financial statements, quarterly

ESCA · Nasdaq · CIK 33488 · [Consumer discretionary](/sectors/consumer-discretionary.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/esca.md) · [Financials](/companies/esca/financials.md) · [Filings](/companies/esca/filings.md) · [Insiders](/companies/esca/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/esca/financials.md?period=annual).

## Income statement

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [65.5 d](/filings/0001437749-25-006863.md) | [57.3](/filings/0001437749-25-014390.md) | [62.5](/filings/0001437749-25-024277.md) | [67.7](/filings/0001437749-25-032415.md) | [63.9 d](/filings/0001437749-26-006094.md) | [55.5](/filings/0001437749-26-013975.md) | [54.3](/filings/0001437749-26-024943.md) | [67.8](/filings/0001437749-26-033847.md) | [62.6 d](/filings/0001437749-26-006094.md) | [55.8](/filings/0001437749-26-013975.md) | [57.7](/filings/0001437749-26-024943.md) | [65.6](/filings/0001437749-26-033847.md) |
| Cost of revenue | $m | [49.6 d](/filings/0001437749-25-006863.md) | [43.0](/filings/0001437749-25-014390.md) | [47.4](/filings/0001437749-25-024277.md) | [50.9](/filings/0001437749-25-032415.md) | [48.0 d](/filings/0001437749-26-006094.md) | [40.7](/filings/0001437749-26-013975.md) | [40.9](/filings/0001437749-26-024943.md) | [48.7](/filings/0001437749-26-033847.md) | [45.2 d](/filings/0001437749-26-006094.md) | [38.6](/filings/0001437749-26-013975.md) | [42.6](/filings/0001437749-26-024943.md) | [46.4](/filings/0001437749-26-033847.md) |
| Selling, general and administrative | $m | [10.4 d](/filings/0001437749-25-006863.md) | [10.7](/filings/0001437749-25-014390.md) | [10.1](/filings/0001437749-25-024277.md) | [11.7](/filings/0001437749-25-032415.md) | [10.9 d](/filings/0001437749-26-006094.md) | [10.6](/filings/0001437749-26-013975.md) | [10.2](/filings/0001437749-26-024943.md) | [11.2](/filings/0001437749-26-033847.md) | [11.6 d](/filings/0001437749-26-006094.md) | [10.7](/filings/0001437749-26-013975.md) | [12.5](/filings/0001437749-26-024943.md) | [11.6](/filings/0001437749-26-033847.md) |
| Operating income | $m | [5.0 d](/filings/0001437749-25-006863.md) | [3.1](/filings/0001437749-25-014390.md) | [4.5](/filings/0001437749-25-024277.md) | [8.0](/filings/0001437749-25-032415.md) | [4.5 d](/filings/0001437749-26-006094.md) | [3.7](/filings/0001437749-26-013975.md) | [2.6](/filings/0001437749-26-024943.md) | [7.3](/filings/0001437749-26-033847.md) | [5.2 d](/filings/0001437749-26-006094.md) | [5.8](/filings/0001437749-26-013975.md) | [11.9](/filings/0001437749-26-024943.md) | [8.7](/filings/0001437749-26-033847.md) |
| Interest expense | $m | [1.1 d](/filings/0001437749-25-006863.md) | [0.7](/filings/0001437749-25-014390.md) | [0.7](/filings/0001437749-25-024277.md) | [0.5](/filings/0001437749-25-032415.md) | [0.3 d](/filings/0001437749-26-006094.md) | [0.2](/filings/0001437749-25-014390.md) | [0.2](/filings/0001437749-25-024277.md) | [0.2](/filings/0001437749-25-032415.md) | [0.2 d](/filings/0001437749-26-006094.md) | [0.2](/filings/0001437749-26-013975.md) | [0.2](/filings/0001437749-26-024943.md) | [0.2](/filings/0001437749-26-033847.md) |
| Income tax | $m | [1.0 d](/filings/0001437749-25-006863.md) | [0.6](/filings/0001437749-25-014390.md) | [0.9](/filings/0001437749-25-024277.md) | [1.8](/filings/0001437749-25-032415.md) | [1.6 d](/filings/0001437749-26-006094.md) | [0.8](/filings/0001437749-26-013975.md) | [0.6](/filings/0001437749-26-024943.md) | [1.6](/filings/0001437749-26-033847.md) | [1.3 d](/filings/0001437749-26-006094.md) | [1.4](/filings/0001437749-26-013975.md) | [2.8](/filings/0001437749-26-024943.md) | [2.0](/filings/0001437749-26-033847.md) |
| Net income | $m | [2.9 d](/filings/0001437749-25-006863.md) | [1.8](/filings/0001437749-25-014390.md) | [2.8](/filings/0001437749-25-024277.md) | [5.7](/filings/0001437749-25-032415.md) | [2.7 d](/filings/0001437749-26-006094.md) | [2.6](/filings/0001437749-26-013975.md) | [1.8](/filings/0001437749-26-024943.md) | [5.6](/filings/0001437749-26-033847.md) | [3.7 d](/filings/0001437749-26-006094.md) | [4.4](/filings/0001437749-26-013975.md) | [9.4](/filings/0001437749-26-024943.md) | [6.7](/filings/0001437749-26-033847.md) |
| Diluted EPS | $ per share | not reported | [0.13](/filings/0001437749-25-014390.md) | [0.20](/filings/0001437749-25-024277.md) | [0.40](/filings/0001437749-25-032415.md) | not reported | [0.19](/filings/0001437749-26-013975.md) | [0.13](/filings/0001437749-26-024943.md) | [0.40](/filings/0001437749-26-033847.md) | not reported | [0.32](/filings/0001437749-26-013975.md) | [0.68](/filings/0001437749-26-024943.md) | [0.48](/filings/0001437749-26-033847.md) |
| Basic EPS | $ per share | not reported | [0.13](/filings/0001437749-25-014390.md) | [0.21](/filings/0001437749-25-024277.md) | [0.41](/filings/0001437749-25-032415.md) | not reported | [0.19](/filings/0001437749-26-013975.md) | [0.13](/filings/0001437749-26-024943.md) | [0.40](/filings/0001437749-26-033847.md) | not reported | [0.32](/filings/0001437749-26-013975.md) | [0.68](/filings/0001437749-26-024943.md) | [0.49](/filings/0001437749-26-033847.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Selling, general and administrative: us-gaap:SellingGeneralAndAdministrativeExpense
- Operating income: us-gaap:OperatingIncomeLoss
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Current assets | $m | [147](/filings/0001437749-25-006863.md) | [151](/filings/0001437749-25-014390.md) | [139](/filings/0001437749-25-024277.md) | [145](/filings/0001437749-25-032415.md) | [134](/filings/0001437749-26-006094.md) | [131](/filings/0001437749-26-013975.md) | [128](/filings/0001437749-26-024943.md) | [141](/filings/0001437749-26-033847.md) | [131](/filings/0001437749-26-033847.md) | [136](/filings/0001437749-26-013975.md) | [144](/filings/0001437749-26-024943.md) | [155](/filings/0001437749-26-033847.md) |
| Total assets | $m | [253](/filings/0001437749-25-006863.md) | [256](/filings/0001437749-25-014390.md) | [243](/filings/0001437749-25-024277.md) | [245](/filings/0001437749-25-032415.md) | [226](/filings/0001437749-26-006094.md) | [222](/filings/0001437749-26-013975.md) | [218](/filings/0001437749-26-024943.md) | [232](/filings/0001437749-26-033847.md) | [222](/filings/0001437749-26-033847.md) | [228](/filings/0001437749-26-013975.md) | [235](/filings/0001437749-26-024943.md) | [246](/filings/0001437749-26-033847.md) |
| Current liabilities | $m | [33.3](/filings/0001437749-25-006863.md) | [34.1](/filings/0001437749-25-014390.md) | [30.2](/filings/0001437749-25-024277.md) | [42.0](/filings/0001437749-25-032415.md) | [34.5](/filings/0001437749-26-006094.md) | [32.4](/filings/0001437749-26-013975.md) | [30.8](/filings/0001437749-26-024943.md) | [42.9](/filings/0001437749-26-033847.md) | [30.5](/filings/0001437749-26-033847.md) | [44.6](/filings/0001437749-26-013975.md) | [45.0](/filings/0001437749-26-024943.md) | [51.6](/filings/0001437749-26-033847.md) |
| Total liabilities | $m | [88.4](/filings/0001437749-25-006863.md) | [91.6](/filings/0001437749-25-014390.md) | [77.1](/filings/0001437749-25-024277.md) | [74.9](/filings/0001437749-25-032415.md) | [57.3](/filings/0001437749-26-006094.md) | [53.3](/filings/0001437749-26-013975.md) | [50.0](/filings/0001437749-26-024943.md) | [60.1](/filings/0001437749-26-033847.md) | [48.9](/filings/0001437749-26-033847.md) | [51.7](/filings/0001437749-26-013975.md) | [51.9](/filings/0001437749-26-024943.md) | [58.5](/filings/0001437749-26-033847.md) |
| Long-term debt | $m | [43.8](/filings/0001437749-25-006863.md) | [46.4](/filings/0001437749-25-014390.md) | [36.0](/filings/0001437749-25-024277.md) | [22.4](/filings/0001437749-25-032415.md) | [18.5](/filings/0001437749-26-006094.md) | [16.7](/filings/0001437749-26-013975.md) | [14.9](/filings/0001437749-26-024943.md) | [13.1](/filings/0001437749-26-033847.md) | [11.3](/filings/0001437749-26-033847.md) | [0.0](/filings/0001437749-26-013975.md) | not reported | [0.0](/filings/0001437749-26-033847.md) |
| Current portion of debt | $m | [7.1](/filings/0001437749-25-006863.md) | [7.1](/filings/0001437749-25-014390.md) | [7.1](/filings/0001437749-25-024277.md) | [7.1](/filings/0001437749-25-032415.md) | [7.1](/filings/0001437749-26-006094.md) | [7.1](/filings/0001437749-26-013975.md) | [7.1](/filings/0001437749-26-024943.md) | [7.1](/filings/0001437749-26-033847.md) | [7.1](/filings/0001437749-26-033847.md) | [16.7](/filings/0001437749-26-013975.md) | [14.9](/filings/0001437749-26-024943.md) | [13.1](/filings/0001437749-26-033847.md) |
| Short-term borrowings | $m | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Shareholders' equity | $m | [165](/filings/0001437749-26-006094.md) | [165](/filings/0001437749-25-024277.md) | [166](/filings/0001437749-25-032415.md) | [170](/filings/0001437749-25-032415.md) | [169](/filings/0001437749-26-033847.md) | [169](/filings/0001437749-26-024943.md) | [168](/filings/0001437749-26-033847.md) | [172](/filings/0001437749-26-033847.md) | [173](/filings/0001437749-26-033847.md) | [176](/filings/0001437749-26-024943.md) | [183](/filings/0001437749-26-033847.md) | [188](/filings/0001437749-26-033847.md) |

- Cash and equivalents: not reported
- Current assets: us-gaap:AssetsCurrent
- Total assets: us-gaap:Assets
- Current liabilities: us-gaap:LiabilitiesCurrent
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebtNoncurrent
- Current portion of debt: us-gaap:LongTermDebtCurrent
- Short-term borrowings: not reported
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [20.6 d](/filings/0001437749-25-006863.md) | [0.0](/filings/0001437749-25-014390.md) | [13.3 d](/filings/0001437749-25-024277.md) | [10.5 d](/filings/0001437749-25-032415.md) | [12.3 d](/filings/0001437749-26-006094.md) | [3.8](/filings/0001437749-26-013975.md) | [13.3 d](/filings/0001437749-26-024943.md) | [(1.0) d](/filings/0001437749-26-033847.md) | [14.9 d](/filings/0001437749-26-006094.md) | [6.1](/filings/0001437749-26-013975.md) | [8.7 d](/filings/0001437749-26-024943.md) | [14.9 d](/filings/0001437749-26-033847.md) |
| Capital expenditure | $m | [0.5 d](/filings/0001437749-25-006863.md) | [0.4](/filings/0001437749-25-014390.md) | [0.8 d](/filings/0001437749-25-024277.md) | [0.3 d](/filings/0001437749-25-032415.md) | [0.6 d](/filings/0001437749-26-006094.md) | [0.5](/filings/0001437749-26-013975.md) | [0.4 d](/filings/0001437749-26-024943.md) | [0.3 d](/filings/0001437749-26-033847.md) | [1.2 d](/filings/0001437749-26-006094.md) | [0.8](/filings/0001437749-26-013975.md) | [0.4 d](/filings/0001437749-26-024943.md) | [1.0 d](/filings/0001437749-26-033847.md) |
| Dividends paid | $m | [0.0 d](/filings/0001437749-25-006863.md) | [2.1](/filings/0001437749-25-014390.md) | [2.1 d](/filings/0001437749-25-024277.md) | [2.1 d](/filings/0001437749-25-032415.md) | [2.1 d](/filings/0001437749-26-006094.md) | [2.1](/filings/0001437749-26-013975.md) | [2.1 d](/filings/0001437749-26-024943.md) | [2.1 d](/filings/0001437749-26-033847.md) | [2.1 d](/filings/0001437749-26-006094.md) | [2.1](/filings/0001437749-26-013975.md) | [2.1 d](/filings/0001437749-26-024943.md) | [2.1 d](/filings/0001437749-26-033847.md) |
| Share repurchases | $m | not reported | not reported | not reported | not reported | [2.2 d](/filings/0001437749-26-006094.md) | [1.4](/filings/0001437749-26-013975.md) | [0.8 d](/filings/0001437749-26-024943.md) | [0.0 d](/filings/0001437749-26-033847.md) | [0.9 d](/filings/0001437749-26-006094.md) | [0.3](/filings/0001437749-26-013975.md) | [1.0 d](/filings/0001437749-26-024943.md) | [0.0 d](/filings/0001437749-26-033847.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [13.6](/filings/0001437749-24-013094.md) | [13.8](/filings/0001437749-24-023485.md) | [13.9](/filings/0001437749-24-031986.md) | [13.9](/filings/0001437749-25-014390.md) | [14.1](/filings/0001437749-25-024277.md) | [14.0](/filings/0001437749-25-032415.md) | [13.9](/filings/0001437749-26-013975.md) | [13.9](/filings/0001437749-26-024943.md) | [13.9](/filings/0001437749-26-033847.md) | [13.9](/filings/0001437749-26-013975.md) | [13.9](/filings/0001437749-26-024943.md) | [13.9](/filings/0001437749-26-033847.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 13,757,134 at 2026-10-21, from the cover of the [10-Q filed 2026-10-29](/filings/0001437749-26-033847.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 29, 2026, 06:29 ET. No prices; not investment advice.